Abstract:Abstract Background Premature coronary artery disease (PCAD) has become more common in recent years and is often associated with poor outcomes. Triglyceride-glucose (TyG) index is a simple and reliable surrogate for insulin resistance (IR) and is an independent predictor of cardiovascular prognosis. However, the prognostic value of the TyG index in patients with PCAD remains uncertain. Thus, this study aimed to investigate the prognostic value and predictive performance of the TyG index in patients with PCAD. Methods A total of 526 young subjects (male < 45 years, female < 55 years) with angiographically proven CAD from January 2013 to December 2018 were included consecutively in this study. Their clinical and laboratory parameters were collected, and the TyG index was calculated as $$\mathrm{Ln}[\mathrm{fasting triglyceride }(\mathrm{TG}) (\mathrm{mg}/\mathrm{dL})\times \mathrm{fasting plasma glucose }(\mathrm{FPG}) (\mathrm{mg}/\mathrm{dL})/2]$$ Ln [ fasting triglyceride ( TG ) ( mg / dL ) × fasting plasma glucose ( FPG ) ( mg / dL ) / 2 ] . The follow-up time after discharge was 40–112 months (median, 68 months; interquartile range, 49‒83 months). The primary endpoint was the occurrence of the major adverse cardiovascular events (MACE), defined as the composite of all-cause death, non-fatal myocardial infarction (MI), coronary artery revascularization, and non-fatal stroke. Results The TyG index was significantly associated with traditional cardiovascular risk factors and the Gensini score (GS). Kaplan–Meier survival (MACE-free) curves by tertiles of the TyG index showed statistically significant differences (log-rank test, p = 0.001). In the fully adjusted Cox regression model, the Hazard ratio (95% CI) of MACE was 2.17 (1.15–4.06) in tertile 3 and 1.45 (1.11–1.91) for per SD increase in the TyG index. Time-dependent ROC analyses of the TyG for prediction of MACE showed the area under the curves (AUC) reached 0.631 at 3 years, 0.643 at 6 years, and 0.710 at 9 years. Furthermore, adding TyG index to existing risk prediction model could improve outcome prediction [C-statistic increased from 0.715 to 0.719, p = 0.007; continuous net reclassification improvement (NRI) = 0.101, p = 0.362; integrated discrimination improvement (IDI) = 0.011, p = 0.017]. Conclusion The TyG index is an independent predictor of MACE in patients with PCAD, suggesting that the TyG index has important clinical implications for risk stratification and early intervention of PCAD.

Triglyceride-Glucose Index Predicts Major Adverse Cardiovascular and Cerebrovascular Events in Patients with Atrial Fibrillation

Association Between the Cumulative Triglyceride-Glucose Index and the Recurrence of Atrial Fibrillation after Radiofrequency Catheter Ablation.

High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome

Prognostic significance of triglyceride-glucose index in acute coronary syndrome patients without standard modifiable cardiovascular risk factors

Association of Triglyceride Glucose-Derived Indices with Recurrent Events Following Atherosclerotic Cardiovascular Disease

Association between triglyceride glucose index and adverse clinical outcomes in patients with acute myocardial infarction and LDL-C≤1.8 mmol/L who underwent percutaneous coronary intervention: a prospective cohort study

Triglyceride-glucose index as a potential predictor of major adverse cardiovascular and cerebrovascular events in patients with coronary heart disease complicated with depression

Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome

Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension

Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease

Triglyceride-glucose Index in the Prediction of Adverse Cardiovascular Events in Patients with Premature Coronary Artery Disease: a Retrospective Cohort Study

Association between triglyceride glucose index and all-cause mortality in patients with cerebrovascular disease: a retrospective study

Association of Triglyceride-Glucose Index with Atherosclerotic Cardiovascular Disease and Mortality among Familial Hypercholesterolemia Patients

U-shaped association between the triglyceride–glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease

Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study

Triglyceride-glucose Index Level and Variability and Outcomes in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: an Observational Cohort Study.

TRIGLYCERIDE GLUCOSE INDEX PREDICTS RISK OF CARDIO-METABOLIC AND MORTALITY OUTCOMES AMONG CHINESE ADULTS - A TERRITORY-WIDE LONGITUDINAL STUDY

High Triglyceride-Glucose Index is Associated With Poor Prognosis in Patients With Acute Coronary Syndrome in Long-Term Follow-Up

Triglyceride glucose index is a risk factor for heart failure: A prospective cohort study

Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes